Datasets
Buyer room
DEEP6.AIManage supplier listing
Deep 6 AI (a Tempus AI company) — Real-time, de-identified clinical data mined from electronic medical records across dozens of health systems — structured codes plus unstructured clinician notes, pathology reports, labs, and genomics/omics — processed via NLP/AI to surface trial-eligible patient cohorts and disease-progression signals, with deep oncology genomic coverage (19,000+ genes, 30,000+ locus-specific mutation names).. Real-time EMR data from 25-45+ health systems (including 7 NCI-designated cancer centers) and 1,000+ research sites per related product pages; ~18-20 employees, $61.9M…
Real-time, de-identified clinical data mined from electronic medical records across dozens of health systems — structured codes plus unstructured clinician notes, pathology reports, labs, and genomics/omics — processed via NLP/AI to surface trial-eligible patient cohorts and disease-progression signals, with deep oncology genomic coverage (19,000+ genes, 30,000+ locus-specific mutation names).
From 10 yearsCoverage Health CareAsset class Equities
Sample, licence terms, pricing and eval results when Deep6 publishes them. Until then, discover alternatives today with a 7-day trial.
Start 7-day trial →What buyers ask about Deep6, answered from this page.
Deep 6 AI (a Tempus AI company) — Real-time, de-identified clinical data mined from electronic medical records across dozens of health systems — structured codes plus unstructured clinician notes, pathology reports, labs, and genomics/omics — processed via NLP/AI to surface trial-eligible patient cohorts and disease-progression signals, with deep oncology genomic coverage (19,000+ genes, 30,000+ locus-specific mutation names).. Real-time EMR data from 25-45+ health systems (including 7 NCI-designated cancer centers) and 1,000+ research sites per related product pages; ~18-20 employees, $61.9M…
Deep6 offers (Alternative) — Real-time EMR data spanning 25-45+ health systems and 1,000+ research sites; genomic coverage of 19,000+ genes and 30,000+ locus-specific mutation names..
Clinical trial patient-matching/recruitment, site feasibility and selection analytics, real-world evidence (RWE) generation, genomic/phenotype-based cohort building, disease-progression modeling for oncology.
The data is with 10 years of history.
Coverage spans US; Health Care Technology; alternative; equities.
Deep6 has not added their own details yet. Not yet on file: